Differences in Clinical and Biochemical Variables Between HYPO and rhTSH Groups
| Variable | HYPO | rhTSH | P |
|---|---|---|---|
| Age (y) | 47.64 ± 11.18 (43.54–51.75) | 48.64 ± 11.53 (44.42–52.87) | 0.73 |
| Sex | 0.32 | ||
| Male | 4 (12.90%) | 7 (22.58%) | |
| Female | 27 (87.10%) | 24 (77.42%) | |
| pT1 | 18 (58.06%) | 20 (64.52%) | 0.60 |
| pT2 | 5 (16.13%) | 1 (3.23%) | 0.19 |
| pT3 | 7 (22.58%) | 10 (32.26%) | 0.39 |
| pT4 | 1 (3.23%) | 0 (0.00%) | 1.00 |
| Papillary histologic type | 20 (64.52%) | 19 (61.29%) | 0.79 |
| Follicular histologic type | 11 (35.48%) | 12 (38.71%) | 0.79 |
| N1 | 2 (6.45%) | 4 (12.90%) | 0.67 |
| TSH at 131I (μU/mL) | 87.37 (76.62–99.72) | 112.80 (98.84–135.80) | 0.01 |
| Thyroglobulin at 131I (ng/mL) | 0.79 (0.25–2.77) | 0.25 (0.20–0.34) | 0.008 |
| Thyroglobulin at 3 mo (ng/mL) | 0.10 (0.10–0.10) | 0.10 (0.10–0.10) | 0.53 |
| Exposure rate at 24 h (mSv/h) | 33 (28–37) | 24 (20–28) | <0.0001 |
| Exposure rate at 48 h (mSv/h) | 16 (12–18) | 9 (8–9) | <0.0001 |
| Creatinine (mg/mL) | 0.98 (0.85–1.05) | 0.76 (0.72–0.80) | <0.0001 |
| Epi-GFR (mL/min) | 74.77 ± 17.50 (68.36–81.19) | 97.61 ± 12.50 (93.03–102.20) | <0.0001 |
Qualitative data are number and percentage; continuous data are mean ± SD or median and 95% CI.